Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nguyen H Tran

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Healthcare (Basel, Switzerland)|May 27, 2026
Hepatocellular Carcinoma in Southeast Asian Americans: Epidemiologic Trends, Screening Challenges, and Policy ImplicationsAhauve M Orusa, Abby M Lohr, Khalid F Abu-Zeinah, et al.
Cancer Metastasis Reviews|August 29, 2021
The role of microbiome in pancreatic cancerJenny Jing Li, Mojun Zhu, Purna C Kashyap, et al.
The American Journal of Surgical Pathology|March 10, 2026
AXIN1 Mutated Hepatocellular CarcinomaMichael Torbenson, Chantal E McCabe, Jessica D Hohenstein, et al.
Therapeutic Advances in Medical Oncology|September 2, 2015
Precision medicine in colorectal cancer: the molecular profile alters treatment strategiesNguyen H Tran, Ludimila L Cavalcante, Sam J Lubner, et al.
The Oncologist|July 9, 2024
Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort studyMichael H Storandt, Tyler J Zemla, Kanchi Patell, et al.
Journal of Gastrointestinal Oncology|September 15, 2025
Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and <i>SMAD4</i> as a predictor of progression-free survivalAhmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Cancers|November 11, 2022
Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular CarcinomaMichael H Storandt, Jennifer J Gile, Mathias E Palmer, et al.
Frontiers in Nuclear Medicine|December 12, 2024
Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypesLaura C Jorgenson, Michael S Torbenson, Thorvardur R Halfdanarson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 5, 2025
Interpretive consistency of a qualitative <sup>68</sup>Ga-PSMA PET framework for treatment response assessment in hepatocellular carcinoma: a head-to-head comparison with cross-sectional imagingAjith Antony, Nguyen H Tran, Nandakumar G Patnam, et al.
Cancers|June 26, 2026
Small Cell and Large Cell Neuroendocrine Carcinoma of the Colon and Rectum: Population-Based Analysis of Incidence, Survival, and Site-Specific OutcomesNora Y Sun, Alexander H Xiao, Thorvardur R Halfdanarson, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Healthcare (Basel, Switzerland)|May 27, 2026
Hepatocellular Carcinoma in Southeast Asian Americans: Epidemiologic Trends, Screening Challenges, and Policy ImplicationsAhauve M Orusa, Abby M Lohr, Khalid F Abu-Zeinah, et al.
Cancer Metastasis Reviews|August 29, 2021
The role of microbiome in pancreatic cancerJenny Jing Li, Mojun Zhu, Purna C Kashyap, et al.
The American Journal of Surgical Pathology|March 10, 2026
AXIN1 Mutated Hepatocellular CarcinomaMichael Torbenson, Chantal E McCabe, Jessica D Hohenstein, et al.
Therapeutic Advances in Medical Oncology|September 2, 2015
Precision medicine in colorectal cancer: the molecular profile alters treatment strategiesNguyen H Tran, Ludimila L Cavalcante, Sam J Lubner, et al.
The Oncologist|July 9, 2024
Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort studyMichael H Storandt, Tyler J Zemla, Kanchi Patell, et al.
Journal of Gastrointestinal Oncology|September 15, 2025
Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and <i>SMAD4</i> as a predictor of progression-free survivalAhmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Cancers|November 11, 2022
Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular CarcinomaMichael H Storandt, Jennifer J Gile, Mathias E Palmer, et al.
Frontiers in Nuclear Medicine|December 12, 2024
Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypesLaura C Jorgenson, Michael S Torbenson, Thorvardur R Halfdanarson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 5, 2025
Interpretive consistency of a qualitative <sup>68</sup>Ga-PSMA PET framework for treatment response assessment in hepatocellular carcinoma: a head-to-head comparison with cross-sectional imagingAjith Antony, Nguyen H Tran, Nandakumar G Patnam, et al.
Cancers|June 26, 2026
Small Cell and Large Cell Neuroendocrine Carcinoma of the Colon and Rectum: Population-Based Analysis of Incidence, Survival, and Site-Specific OutcomesNora Y Sun, Alexander H Xiao, Thorvardur R Halfdanarson, et al.
Pageof 6